MINI REVIEW published : 31 March 2020 doi : 10 . 3389 / fcimb . 2020 . 00123 Frontiers in Cellular and Infection Microbiology | www . frontiersin . org 1 March 2020 | Volume 10 | Article 123 Edited by : Vernon L . Tesh , Texas A & M University , United States Reviewed by : Ludger Johannes , Maria Sklodowska Curie Institute of Oncology , Poland Angela Melton - Celsa , Uniformed Services University , United States * Correspondence : Clifford Lingwood cling @ sickkids . ca Specialty section : This article was submitted to Molecular Bacterial Pathogenesis , a section of the journal Frontiers in Cellular and Infection Microbiology Received : 27 November 2019 Accepted : 05 March 2020 Published : 31 March 2020 Citation : Lingwood C ( 2020 ) Verotoxin Receptor - Based Pathology and Therapies . Front . Cell . Infect . Microbiol . 10 : 123 . doi : 10 . 3389 / fcimb . 2020 . 00123 Verotoxin Receptor - Based Pathology and Therapies Clifford Lingwood * Molecular Medicine , Research Institute , Hospital for Sick Children , Toronto , ON , Canada Verotoxin , VT ( aka Shiga toxin , Stx ) is produced by enterohemorrhagic E . coli ( EHEC ) and is the key pathogenic factor in EHEC - induced hemolytic uremic syndrome ( eHUS - hemolytic anemia / thrombocytopenia / glomerular infarct ) which can follow gastrointestinal EHEC infection , particularly in children . This AB5 subunit toxin family bind target cell globotriaosyl ceramide ( Gb 3 ) , a glycosphingolipid ( GSL ) ( aka CD77 , pk blood group antigen ) of the globoseries of neutral GSLs , initiating lipid raft - dependent plasma membrane Gb 3 clustering , membrane curvature , invagination , scission , endosomal trafﬁcking , and retrograde trafﬁc via the TGN to the Golgi , and ER . In the ER , A / B subunits separate and the A subunit hijacks the ER reverse translocon ( dislocon - used to eliminate misfolded proteins - ER associated degradation - ERAD ) for cytosolic access . This property has been used to devise toxoid - based therapy to temporarily block ERAD and rescue the mutant phenotype of several genetic protein misfolding diseases . The A subunit avoids cytosolic proteosomal degradation , to block protein synthesis via its RNA glycanase activity . In humans , Gb 3 is primarily expressed in the kidney , particularly in the glomerular endothelial cells . Here , Gb 3 is in lipid rafts ( more ordered membrane domains which accumulate GSLs / cholesterol ) whereas renal tubular Gb 3 is in the non - raft membrane fraction , explaining the basic pathology of eHUS ( glomerular endothelial infarct ) . Females are more susceptible and this correlates with higher renal Gb 3 expression . HUS can be associated with encephalopathy , more commonly following verotoxin 2 exposure . Gb 3 is expressed in the microvasculature of the brain . All members of the VT family bind Gb 3 , but with varying afﬁnity . VT2e ( pig edema toxin ) binds Gb 4 preferentially . Verotoxin - speciﬁc therapeutics based on chemical analogs of Gb 3 , though effective in vitro , have failed in vivo . While some analogs are effective in animal models , there are no good rodent models of eHUS since Gb 3 is not expressed in rodent glomeruli . However , the mouse mimics the neurological symptoms more closely and provides an excellent tool to assess therapeutics . In addition to direct cytotoxicity , other factors including VT – induced cytokine release and aberrant complement cascade , are now appreciated as important in eHUS . Based on atypical HUS therapy , treatment of eHUS patients with anticomplement antibodies has proven effective in some cases . A recent switch using stem cells to try to reverse , rather than prevent VT induced pathology may prove a more effective methodology . Keywords : lipid raft , retrograde transport , endothelial cell , astrocyte , hemolytic uremic syndrome Lingwood Receptor Based Pathology INTRODUCTION Originally termed Verotoxin ( VT ) , because of its discovery as a novel enterohemorrhagic E coli ( O157 : H7 ) derived toxin eﬀective against the vero African green monkey kidney cell line ( Konowalchuk et al . , 1977 ) , but currently more frequently termed Shiga toxin or Shiga - like toxin due to its single amino acid diﬀerence with Shiga toxin ( Stx ) from Shigella dysenteriae ( DeGrandis et al . , 1987 ) . EHEC produced Verotoxin 1 was shown , in Karmali’s landmark studies ( Karmali et al . , 1985 ) , to be responsible for the hemolytic uremic syndrome , a renal glomerular pathology with a triad of symptoms : thrombocytopenia , hemolytic anemia , and glomerular endothelial infarct , with no previously deﬁned cause . Unfortunately , antibiotic treatment increases rather than reduces pathology ( Zhang et al . , 2000 ) . Females are more susceptible and this correlates with increased renal Gb 3 ( Fujii et al . , 2016 ) . With a fatality rate of ∼ 10 % and highest incidence in the pediatric and elderly population , it is of concern that since the infectious cause was deﬁned 35 years ago , no speciﬁc therapeutic approach has been achieved . EHEC TOXINS The Shiga ( vero ) toxins are a family of AB5 bacterial subunit toxins , primarily comprising VT1 and VT2 ( Nakao and Takeda , 2000 ) [ though many other minor variants of VT2 are known ( Zhang et al . , 2008 ) ] . VT2 is 60 % identical but signiﬁcantly less toxic than VT1 in cell culture ( Fuller et al . , 2011 ) . VT2 binds Gb 3 with lower aﬃnity ( Nakajima et al . , 2001 ) but VT2 causes increased toxicity in mice ( Conrady et al . , 2010 ; Fuller et al . , 2011 ) and other animal models ( Mizuguchi et al . , 2001 ; Takahashi et al . , 2008 ) with increased association with disease ( Kawano et al . , 2008 ) , particularly neurological sequelae following EHEC infection ( Trachtman et al . , 2012 ; Kramer et al . , 2015 ) . The diﬀerent toxicity potency is due to B subunit diﬀerences ( Head et al . , 1991 ) . VT RECEPTOR The receptor binding pentameric B subunit of Shiga toxin binds the neutral glycosphingolipid ( GSL ) , globotriaosyl ceramide ( Gb 3 , aka CD77 and the p k blood group antigen ) ( Lingwood et al . , 1987 ) , which is highly expressed in the human kidney ( Boyd and Lingwood , 1989 ; Lingwood , 1994 ) . GSLs are sugar - ceramide conjugates , for the most part , based on the ceramide monohexoside , glucosyl ceramide . Single sugar units are added in α or β anomeric linkage to form linear or branch chain GSLs in the Golgi membrane , which are then transported to the plasma membrane by vesicular traﬃc . Over 400 carbohydrate structures have been deﬁned ( Stults et al . , 1989 ) . The structure of Gb 3 is galactose α 1 - 4 galactose β 1 - 4 glucosyl ceramide . The terminal gal α 1 - 4 gal is bound by the VT B subunit pentamer , but the lipid moiety is necessary for high aﬃnity binding . While Gb 3 is the receptor for VTs from human EHEC pathogens , VT2e from the pig EHEC binds Gb 4 , the next member of the globoseries GSLs which contains an additional β 1 - 3 galNAc ( DeGrandis et al . , 1989 ) . Interestingly , although VT1 and VT2 do not bind Gb 4 , they bind ( non - physiological ) deacetylGb 4 ( terminal free amino sugar ) in preference to Gb 3 ( Nyholm et al . , 1996 ) . Diﬀerential chemical substitution of this free amine has a remarkable and varied eﬀect on the binding of diﬀerent VTs ( Mylvaganam et al . , 2015 ) . The binding aﬃnity for the lipid - free gal α 1 - 4 gal disaccharide is many orders less than for Gb 3 ( St . Hilaire et al . , 1994 ) . The ceramide lipid component of Gb 3 ( and all GSLs ) varies greatly and this has a major eﬀect on VTB : Gb 3 binding ( Pellizzari et al . , 1992 ; Kiarash et al . , 1994 ) . The orientation of the carbohydrate of membrane GSLs is dependent on both the lipid composition of the GSL itself and the membrane in which it is embedded ( Nyholm et al . , 1989 ; Nyholm and Pascher , 1993 ) . Moreover , GSLs accumulate in ( detergent resistant ) cholesterol enriched lipid rafts ( Hooper , 1999 ; Legros et al . , 2017 ) . RETROGRADE TRANSPORT The presence of Gb 3 in lipid plasma membrane rafts is required for the retrograde transport of internalized VT to the ER ( Falguieres et al . , 2001 ) . Non - raft Gb 3 targets internalized VT to lysosomes for degradation . Receptor mediated VT cell internalization is via clathrin dependent and independent mechanisms ( Khine et al . , 2004 ) . The multivalent B subunit pentamer binding to cell surface raft and model membrane Gb 3 has been shown to cluster Gb 3 ( Khine and Lingwood , 1994 ; Windschiegl et al . , 2009 ; Pezeshkian et al . , 2017 ) which causes subsequent energy and clathrin independent tubular invaginations ( negative membrane curvature ) ( Römer et al . , 2007 ; Bosse et al . , 2019 ) ( Figure 1 ) . This eﬀect is Gb 3 unsaturated fatty acid dependent and does not involve cytoskeletal components ( Römer et al . , 2007 ) . Pinching oﬀ of the vesicles occurs after actin mediated , cholesterol dependent membrane domain reorganization ( Römer et al . , 2010 ) . Membrane incorporation of lysophospholipids with large head groups blocks VT membrane Gb 3 binding and can reverse Gb 3 bound VT ( Ailte et al . , 2016 ) . These phospholipids induce a positive membrane curvature which may prevent the negative membrane curvature induced by VT - Gb 3 binding . Control of endosomal VT / Gb 3 sorting to the transGolgi network for retrograde transport to the Golgi and ER , is achieved by a large array of traﬃcking regulators ( Figure 1 ) . However , cell bound VT1 and VT2 reach this sorting pathway by diﬀerent routes ( Tam et al . , 2008 ) . The A subunit is proteolytically clipped by furin ( Lea et al . , 1999 ) in the Golgi ( Voorhees et al . , 1995 ) , but the C terminal disulﬁde bond holding the A1 and A2 peptides together is only cleaved in the ER where the A1 subunit separates from the B pentamer , and , via its newly exposed C terminal misfolded protein - mimic sequence ( Hazes and Read , 1997 ) , hijacks the ER chaperone quality control system to be unfolded and transported via the ER dislocon into the cytosol ( Yu and Haslam , 2005 ; Tam and Lingwood , 2007 ) for inhibition of protein synthesis / cell killing via RNA glycanase activity ( Endo and Tsurugi , 1987 ) . Since this dislocon is key in ER associated degradation of misfolded proteins ( Hebert et al . , 2010 ) , this Frontiers in Cellular and Infection Microbiology | www . frontiersin . org 2 March 2020 | Volume 10 | Article 123 Lingwood Receptor Based Pathology FIGURE 1 | Basis of cellular VT cytopathology . The retrograde transport of plasma membrane bound VT ( Römer et al . , 2007 ) is the central determinant of cytopathology . Receptor mediated endocytosis ( Sandvig et al . , 1989 ; Khine et al . , 2004 ; Bujny et al . , 2007 ; Rydell et al . , 2014 ; Renard et al . , 2015 ) , tyrosine kinase activation ( Katagiri et al . , 1999 ; Mori et al . , 2000 ; Lauvrak et al . , 2005 ; Utskarpen et al . , 2010 ) , non - raft Gb 3 bound VT lysosomal transit ( Falguieres et al . , 2001 ) raft Gb 3 bound VT endosomal / TGN transit [ and A subunit ER / cytosolic transport ] ( Lord et al . , 2003 ; Spooner and Lord , 2012 ) are all essential to end stage cytopathology ( Brigotti et al . , 1997 ; Foster et al . , 2000 ; Fujii et al . , 2003 ; Yamasaki et al . , 2004 ; Jandhyala et al . , 2008 ; Stearns - Kurosawa et al . , 2010 ; Leyva - Illades et al . , 2012 ; Debernardi et al . , 2018 ) . These control points provide candidates for the prevention of VT cytopathology . However , they also control retrograde transport in general , and although no physiological substrate for retrograde transport has yet been described , the potential for side effects persists . hijacking can be used therapeutically in protein misfolding diseases ( Adnan et al . , 2016 ) . Gb 3 BINDING In the human renal glomerulus , Gb 3 is in lipid rafts whereas in tubular cells , Gb 3 is in the non - raft fraction ( Khan et al . , 2009 ) . This correlates with the glomerular site of primary pathology in eHUS . However , the interaction of cholesterol with GSLs can markedly restrict the orientation of the membrane GSL carbohydrate moiety for ligand binding ( Mahfoud et al . , 2010 ; Yahi et al . , 2010 ; Lingwood et al . , 2011 ) . Site speciﬁc mutagenesis and molecular modeling from the B subunit crystal structure ( Stein et al . , 1992 ) identiﬁed 3 potential Gb 3 binding sites ( Nyholm et al . , 1989 ; Ling et al . , 1998 ; Bast et al . , 1999 ; Soltyk et al . , 2002 ) . Site 1 is in the interface between B subunits , site 2 is a shallow groove on the membrane apposed B subunit surface and site 3 is the single central tryptophan34 . Thermodynamically site 1 is the high aﬃnity site ( Nyholm et al . , 1996 ) but cocrystalization with a gal α 1 - 4 gal carbohydrate showed site 2 was most frequently occupied ( Ling et al . , 1998 ) . It remains likely that site 1 is the Gb 3 glycolipid binding site but site 2 has been targeted using gal α 1 - 4 gal β 1 - 4 glc sugar derivatives as a potential prophylactic approach ( Ling et al . , 1998 ) . Frontiers in Cellular and Infection Microbiology | www . frontiersin . org 3 March 2020 | Volume 10 | Article 123 Lingwood Receptor Based Pathology RECEPTOR ANALOGS Synsorb p k was the ﬁrst wherein gal α 1 - 4 gal β 1 - 4 glc oligosaccharide was coupled to an inert silica matrix ( Armstrong et al . , 1991 ) . This was eﬀective to block cytotoxicity in cell culture but not in a randomized clinical trial ( Armstrong et al . , 1995 ; Trachtman et al . , 2003 ) . Multimeric derivatives ( Watanabe et al . , 2004 ; Nishikawa et al . , 2005 ; Jacobson et al . , 2014 ; Matsuoka et al . , 2018 ) [ particularly the pentameric “starﬁsh” array ( Kitov et al . , 2000 ; Mulvey et al . , 2003 ) ] have been used to increase binding avidity generating a “sandwich” whereby the polymeric galactose α 1 - 4 galactose disaccharide binds to two B subunit pentameric arrays ( Kitov et al . , 2000 ) . This sandwich structure prevents cell surface Gb 3 binding to block toxicity . Although eﬀective in cell culture and the mouse to prevent VT cytotoxicity ( Kitov et al . , 2008a ) , the compound has yet to be tested clinically as a prophylactic for HUS . Gb 3 carbohydrate multimerically coupled to a series of acrylamide polymers also proved eﬀective inhibitors of VT cytopathology in cell culture and in mice ( Nishikawa et al . , 2005 ; Watanabe et al . , 2006 ; Watanabe - Takahashi et al . , 2010 ) . A Gb 3 - trehalose acrylamide copolymer was also eﬀective against VT in cell culture and the mouse model ( Neri et al . , 2007a ) . However acrylamide is toxic in vivo ( Tareke et al . , 2002 ) . In optimization studies of these complexes , it was found the VT 1 and VT2 bind to completely diﬀerent regions of the Gb 3 oligosaccharide ( Watanabe et al . , 2006 ) , a result consistent with our earlier observation that VT1 and VT2 bind preferentially to diﬀerent conformers of Gb 3 ( Nyholm et al . , 1996 ) . A tetravalent peptide was developed ( Nishikawa et al . , 2006 ) which prevented the traﬃc of VT to the ER in cell culture and prevented VT2 - induced ﬂuid accumulation in rabbit ileal loops ( Watanabe - Takahashi et al . , 2010 ) . Gb 3 oligosaccharides complexed with cyclodextrin proved high aﬃnity receptors for both VT1 and VT2 ( Zhang et al . , 2017 ) but not as yet reported for neutralization . Other Gb 3 mimics have been selected from peptide libraries ( Miura et al . , 2004 , 2006 ) which are bound by VTs ( and antiGb 3 ) . These were protective in cell culture . However , peptides can be immunogenic and were not tested clinically . Gb 3 sugar coupled to phosphatidylethanolamine in a liposomal format also proved eﬀective against VT in cell culture ( Neri et al . , 2007b ; Detzner et al . , 2019 ) . A unique Gb 3 sugar based heterobifunctional crosslinker was made to decorate the pentameric serum amyloid P to block VT1 / VT2 in vitro but rapid clearance prevented in vivo eﬃcacy ( Kitov et al . , 2008b ) . A similar construct using a GalNAc instead of a Gal Gb3 trisaccharide selectively blocked VT2 in vivo ( Jacobson et al . , 2014 ) . The sugar sequence of Gb 3 is mimicked by the carbohydrate moiety of some bacterial lipooligosaccharides ( Mandrell and Apicella , 1993 ) . The bacterial β - galactosyl and α - galactosyl transferases responsible from Neiseria were cloned into a commensal E . coli expressing glucose terminating LPS ( Paton et al . , 2000 ) . This E . coli proved eﬀective to protect cells and animal models against VT pathology ( Paton A . W . et al . , 2001 ) . A similar Gb 4 - LPS E . coli was protective in pig edema disease ( Paton A . W . et al . , 2001 ; Hostetter et al . , 2014 ) . These constructs were further modiﬁed to be suitable for clinical trial ( Paton J . C . et al . , 2001 ) and non - genetically modiﬁed “Gb 3 ” expressing bacterial “ghosts” also were eﬀective ( Paton et al . , 2015 ) , but as yet no clinical trials have been reported . Our approach was to target the B subunit Gb 3 glycolipid binding site , site1 ( Nyholm et al . , 1996 ) . Since the binding aﬃnity for the lipid - free trisaccharide of Gb 3 is so low , we attempted to generate a “water soluble” Gb 3 analog ( Mylvaganam and Lingwood , 1999 ) . We found that substituting the fatty acid of GSLs with an adamantane frame generated species which partitioned into water yet retained similar hydrophobicity as monitored by thin layer chromatogram mobility ( Lingwood and Mylvaganam , 2003 ) . Although the fatty acid is important in VT - Gb 3 binding ( Kiarash et al . , 1994 ; Pezeshkian et al . , 2015 ) , these species ( unlike the free sugar ) retained the biological activity of the membrane embedded GSL in solution ( Lingwood et al . , 2006 ) . AdaGlcCer and adaGalCer proved eﬀective inhibitors of cellular GSL biosynthesis ( Kamani et al . , 2011 ) , while adaSGC was an eﬀective mimic of SGC ( 3 - sulfogalactosyl ceramide ) , binding to Hsp70 ( Mamelak and Lingwood , 2001 ) , thereby inhibiting its ATPase activity ( Whetstone and Lingwood , 2003 ) and chaperone action in cells ( Park et al . , 2009 ) . Hsp70 - SGC binding promotes aggregation of Hsp70 for high aﬃnity peptide binding and blocks ATP - mediated peptide release ( Harada et al . , 2015 ) . AdamantylGb 3 is a highly eﬀective receptor for the VTB subunit ( Mylvaganam and Lingwood , 1999 ; Lingwood et al . , 2006 ) . AdaGb 3 is bound by VT2 more eﬀectively than Gb 3 ( Saito et al . , 2012 ) . AdaGb 3 blocks VT – Gb 3 and cell binding in vitro ( Mylvaganam and Lingwood , 1999 ) . We made several lipid derivatives of adaGb 3 . However , adaGb 3 and derivatives can incorporate into Gb 3 negative cell lines and induce VT1 / 2 sensitivity ( Saito et al . , 2012 ) . This is interesting , since the diﬀerent analogs can diﬀerentially subvert the intracellular traﬃc of VT ( Saito et al . , 2012 ) , but is not a feature consistent with a therapeutic . We therefore made an adamantyl bis Gb 3 which has two deacylGb 3 s linked to a single central adamantane frame . This protected cells from VT more eﬀectively than adaGb 3 and was not incorporated into receptor negative cells ( Saito et al . , 2012 ) . Despite protection against VT in cell culture , subsequent in vivo mouse susceptibility studies with adabisGb 3 showed that treated mice showed a more rapid VT - induced pathology than control mice . A similar eﬀect has been reported for lysoGb 3 containing liposomes in vivo ( Takenaga et al . , 2000 ) . While the basis of this eﬀect in not clear , it may relate to the potential of multivalent VT to show cooperative receptor binding ( Peter and Lingwood , 2000 ) . VT AND eHUS The pathology of eHUS is complex . In the baboon model , sterile VT was clearly shown to induce HUS following intravenous administration ( Siegler et al . , 2003 ) . The question of how VT enters the blood stream following gastrointestinal EHEC infection , is still unclear . VT is diﬃcult to detect in patient blood after EHEC infection but can be detected in the acute phase ( He et al . , 2015 ; Yamada et al . , 2019 ) . However , these blood Frontiers in Cellular and Infection Microbiology | www . frontiersin . org 4 March 2020 | Volume 10 | Article 123 Lingwood Receptor Based Pathology concentrations are far lower than needed to cause HUS in the baboon . Moreover , if the VT dose inducing HUS in baboon was divided into 4 ( still much higher than ever detected in eHUS patients ) and given every 12 h , no HUS pathology was observed ( Siegler R . et al . , 2001 ) . Signiﬁcantly , Gb 3 is upregulated in many human cancers ( LaCasse et al . , 1999 ; Kovbasnjuk et al . , 2005 ; Distler et al . , 2009 ; Stimmer et al . , 2014 ) . In light of the baboon data indicating there could be a “safe” dose for sterile VT , we ( Farkas - Himsley et al . , 1995 ; Arab et al . , 1999 ; Arbus et al . , 2000 ) and later others ( Gariepy , 2001 ; Falguieres et al . , 2008 ; Devenica et al . , 2011 ; Engedal et al . , 2011 ) , have proposed VT could be used as the basis of an antineoplastic . OTHER FACTORS IN eHUS It is clear that other systemic factors are at play in eHUS . One of these is bacterial LPS , which augments baboon VT renal toxicity ( Siegler R . L . , et al . , 2001 ) and renal Gb 3 ( Clayton et al . , 2005 ) . LPS can induce proinﬂammatory cytokines TNF and IL1 β ( Eggesbo et al . , 1996 ) which in turn , can increase cell Gb 3 synthesis ( Warnier et al . , 2006 ) and VT sensitivity ( Louise and Obrig , 1991 ) . VT itself can induce TNF production ( van Setten et al . , 1996 ) by monocytes . These cells are not sensitive to VT toxicity but the A subunit is required ( Foster et al . , 2000 ) ( Figure 1 ) . This cytokine has been recently shown to play a role to set VT sensitivity in eHUS ( Brigotti et al . , 2018 ; Lafalla Manzano et al . , 2019 ) . VT interaction with neutrophils has also been suggested to be important . Gb 3 is not expressed in the human colonic epithelium ( Miyamoto et al . , 2006 ) and so the mechanism by which gastrointestinal VT gains systemic access remains to be answered . Several studies suggest a VT - neutrophil transport function ( Hurley et al . , 2001 ; Griener et al . , 2007 ; Brigotti et al . , 2008 , 2010 ) . Other work , however , concluded VT does not bind human neutrophils ( Flagler et al . , 2007 ; Geelen et al . , 2007 ) , although mouse neutrophils were bound ( Fernandez et al . , 2000 , 2006 ) and can target mouse kidney ( Roche et al . , 2007 ) . Nevertheless , recent studies show neutrophil released traps [ NETs - anti infectious / inﬂammatory response ( Boeltz et al . , 2019 ) ] are increased ( Ramos et al . , 2016 ) and their degradation reduced ( Leﬄer et al . , 2017 ) in eHUS . Since complement insuﬃciency plays a central role in idiopathic thrombocytopenia and atypical HUS ( Nielsen et al . , 1994 ) , VT activation of the alternative complement pathway ( Morigi et al . , 2011 ) has become considered of potential importance in eHUS ( Karpman and Tati , 2016 ; Fakhouri and Loirat , 2018 ) . However , these interactions of VT with diﬀerent components of the blood system should be reviewed in light of the diﬀerences showed for the binding of native vs . proteolytically clipped VT recently reported ( Brigotti et al . , 2019 ) . NEW THERAPEUTICS Complement The treatment of acquired or congenital thrombocytopenia with Eculizumab , an anti - C5 monoclonal antibody which blocks complement activation , has proven successful ( Pecoraro et al . , 2015 ; Bitzan et al . , 2018 ) . Since VT can activate complement , this approach has been tested for eﬃcacy in eHUS ( Rasa et al . , 2017 ; Walsh and Johnson , 2019 ) . Therapeutic eﬀect has been shown , particularly for patients with neurological symptoms ( Percheron et al . , 2018 ) but results overall are , as yet , highly variable ( Loos et al . , 2018 ; Monet - Didailler et al . , 2019 ) . Stem Cells Advantage has recently been taken of the huge eﬀort to develop stem cells as disease therapeutics . Muse ( multilineage diﬀerentiating stress enduring ) cells are a small non - tumorigenic , non - immunogenic component of the mesenchymal stem cell fraction ( Kuroda et al . , 2010 ) which can be isolated from many sources ( Leng et al . , 2019 ) , including bone marrow , adipose tissue and ﬁbroblasts . Muse cells home to sites of tissue damage and there diﬀerentiate to regenerate the damaged tissue type ( Young , 2018 ) . This includes neuronal cells ( Nitobe et al . , 2019 ) . There are many current clinical trials based on these cells ( Dezawa , 2018 ; Kuroda et al . , 2018 ) . Human Muse cells were used to rescue a NOD - SCID mouse model of EHEC ( VT2 ) induced neurological disease ( Ozuru et al . , 2019 ) . Forty eight hour after gastrointestinal EHEC treatment Muse cell i . v . injection resulted in complete survival and lack of weight loss , whereas > 50 % of untreated mice died of encephalopathy . Splitting the Muse cell dosage and treating at 24 and 48 h post - infection did not give protection . Human Muse cells were found in the mouse brain and the level of VT2 activated astrocytes signiﬁcantly reduced . Knockdown of G - CSF largely ablated the protection . These studies bode well for the development of an eﬀective means to prevent / treat VT - based disease in the future . AUTHOR CONTRIBUTIONS The author conﬁrms being the sole contributor of this work and has approved it for publication . REFERENCES Adnan , H . , Zhang , Z . , Park , H . J . , Tailor , C . , Che , C . , Kamani , M . , et al . ( 2016 ) . Endoplasmic reticulum - targeted subunit toxins provide a new approach to rescue misfolded mutant proteins and revert cell models of genetic diseases . PLoS ONE 11 : e0166948 . doi : 10 . 1371 / journal . pone . 0166948 Ailte , I . , Lingelem , A . B . , Kavaliauskiene , S . , Bergan , J . , Kvalvaag , A . S . , Myrann , A . G . , et al . ( 2016 ) . Addition of lysophospholipids with large head groups to cells inhibits Shiga toxin binding . Sci . Rep . 6 : 30336 . doi : 10 . 1038 / srep30336 Arab , S . , Rutka , J . , and Lingwood , C . ( 1999 ) . Verotoxin induces apoptosis and the complete , rapid , long - term elimination of human astrocytoma xenografts in nude mice . Oncol . Res . 11 , 33 – 39 . Frontiers in Cellular and Infection Microbiology | www . frontiersin . org 5 March 2020 | Volume 10 | Article 123 Lingwood Receptor Based Pathology Arbus , G . S . , Grisaru , S . , Segal , O . , Dosch , M . , Pop , M . , Lala , P . , et al . ( 2000 ) . Verotoxin targets lymphoma inﬁltrates of patients with post - transplant lymphoproliferative disease . Leukemia Res . 24 , 857 – 864 . doi : 10 . 1016 / S0145 - 2126 ( 00 ) 00060 - 6 Armstrong , G . D . , Fodor , E . , and Vanmaele , R . ( 1991 ) . Investigation of Shiga - like toxin binding to chemically synthesized oligosaccharide sequences . J . Infect . Dis . 164 , 1160 – 1167 . doi : 10 . 1093 / infdis / 164 . 6 . 1160 Armstrong , G . D . , Rowe , P . C . , Goodyer , P . , Orrbine , E . , Klassen , T . P . , Wells , G . , et al . ( 1995 ) . A phase 1 study of chemically synthesized verotoxin ( shiga - like toxin ) Pk - trisaccharide receptors attached to chromosorb for preventing Hemolytic Uremic Syndrome ( HUS ) . J . Infect . Dis . 171 , 1042 – 1045 . doi : 10 . 1093 / infdis / 171 . 4 . 1042 Bast , D . J . , Banerjee , L . , Clark , C . , Read , R . J . , and Brunton , J . L . ( 1999 ) . The identiﬁcation of three biologically relevant globotriaosyl ceramide receptor binding sites on the verotoxin 1 B subunit . Mol . Microbiol . 32 , 953 – 960 . doi : 10 . 1046 / j . 1365 - 2958 . 1999 . 01405 . x Bitzan , M . , Hammad , R . M . , Bonnefoy , A . , Al Dhaheri , W . S . , Vezina , C . , and Rivard , G . E . ( 2018 ) . Acquired thrombotic thrombocytopenic purpura with isolated CFHR3 / 1 deletion - rapid remission following complement blockade . Pediatr . Nephrol . 33 , 1437 – 1442 . doi : 10 . 1007 / s00467 - 018 - 3957 - 8 Boeltz , S . , Amini , P . , Anders , H . J . , Andrade , F . , Bilyy , R . , Chatﬁeld , S . , etal . ( 2019 ) . To NET or not to NET : current opinions and state of the science regarding the formation of neutrophil extracellular traps . Cell Death Diﬀer . 26 , 395 – 408 . doi : 10 . 1038 / s41418 - 018 - 0261 - x Bosse , M . , Sibold , J . , Scheidt , H . A . , Patalag , L . J . , Kettelhoit , K . , Ries , A . , et al . ( 2019 ) . Shiga toxin binding alters lipid packing and the domain structure of Gb3 - containingmembranes : asolid - stateNMRstudy . Phys . Chem . Chem . Phys . 21 , 15630 – 15638 . doi : 10 . 1039 / C9CP02501D Boyd , B . , and Lingwood , C . A . ( 1989 ) . Verotoxin receptor glycolipid in human renal tissue . Nephron 51 , 207 – 210 . doi : 10 . 1159 / 000185286 Brigotti , M . , Carnicelli , D . , Alvergna , P . , Mazzaracchio , R . , Sperti , S . , and Montanaro , L . ( 1997 ) . The RNA - N - glycosidase activity of Shiga - like toxin I : kinetic parameters of the native and activated toxin . Toxicon 35 , 1431 – 1437 . doi : 10 . 1016 / S0041 - 0101 ( 96 ) 00225 - 5 Brigotti , M . , Carnicelli , D . , Arﬁlli , V . , Porcellini , E . , Galassi , E . , Valerii , M . C . , et al . ( 2018 ) . Human monocytes stimulated by Shiga toxin 1a via globotriaosylceramide release proinﬂammatory molecules associated with hemolytic uremic syndrome . Int . J . Med . Microbiol . 308 , 940 – 946 . doi : 10 . 1016 / j . ijmm . 2018 . 06 . 013 Brigotti , M . , Carnicelli , D . , Ravanelli , E . , Barbieri , S . , Ricci , F . , Bontadini , A . , et al . ( 2008 ) . Interactions betweenShiga toxins and human polymorphonuclear leukocytes . J . Leukoc . Biol . 84 , 1019 – 1027 . doi : 10 . 1189 / jlb . 0308157 Brigotti , M . , Orth - Holler , D . , Carnicelli , D . , Porcellini , E . , Galassi , E . , Tazzari , P . L . , et al . ( 2019 ) . The structure of the Shiga toxin 2a A - subunit dictates the interactions of the toxin with blood components . Cell Microbiol . 21 : e13000 . doi : 10 . 1111 / cmi . 13000 Brigotti , M . , Tazzari , P . L . , Ravanelli , E . , Carnicelli , D . , Barbieri , S . , Rocchi , L . , et al . ( 2010 ) . Endothelial damage induced by Shiga toxins delivered by neutrophils during transmigration . J . Leukoc . Biol . 88 , 201 – 210 . doi : 10 . 1189 / jlb . 07 09475 Bujny , M . V . , Popoﬀ , V . , Johannes , L . , and Cullen , P . J . ( 2007 ) . The retromer component sorting nexin - 1 is required for eﬃcient retrograde transport of Shiga toxin from early endosome to the trans Golgi network . J . Cell Sci . 120 , 2010 – 2021 . doi : 10 . 1242 / jcs . 003111 Clayton , F . , Pysher , T . J . , Lou , R . , Kohan , D . E . , Denkers , N . D . , Tesh , V . L . , et al . ( 2005 ) . Lipopolysaccharide upregulates renal shiga toxin receptors in a primate model of hemolytic uremic syndrome . Am . J . Nephrol . 25 , 536 – 540 . doi : 10 . 1159 / 000088523 Conrady , D . G . , Flagler , M . J . , Friedmann , D . R . , VanderWielen , B . D . , Kovall , R . A . , Weiss , A . A . , etal . ( 2010 ) . MolecularbasisofdiﬀerentialB - pentamerstabilityof Shiga toxins 1 and 2 . PLoS ONE 5 : e15153 . doi : 10 . 1371 / journal . pone . 0015153 Debernardi , J . , Hollville , E . , Lipinski , M . , Wiels , J . , and Robert , A . ( 2018 ) . Diﬀerential role of FL - BID and t - BID during verotoxin - 1 - induced apoptosis in Burkitt’s lymphoma cells . Oncogene 37 , 2410 – 2421 . doi : 10 . 1038 / s41388 - 018 - 0123 - 5 DeGrandis , S . , Law , H . , Brunton , J . , Gyles , C . , and Lingwood , C . A . ( 1989 ) . Globotetraosyl ceramide is recognized by the pig edema disease toxin . J . Biol . Chem . 264 , 12520 – 12525 . DeGrandis , S . A . , Ginsberg , J . , Toone , M . , Climie , S . , Friesen , J . , and Brunton , J . ( 1987 ) . Nucleotide sequence and promoter mapping of the Escherichia coli Shiga - liketoxinoperationofbacteriophageH - 19B . J . Bacteriol . 169 , 4313 – 4319 . doi : 10 . 1128 / JB . 169 . 9 . 4313 - 4319 . 1987 Detzner , J . , Gloerfeld , C . , Pohlentz , G . , Legros , N . , Humpf , H . U . , Mellmann , A . , et al . ( 2019 ) . Structural insights into Escherichia coli Shiga Toxin ( Stx ) glycosphingolipid receptors of porcine renal epithelial cells and inhibition of stx - mediated cellular injury using neoglycolipid - spiked glycovesicles . Microorganisms 7 : E582 . doi : 10 . 3390 / microorganisms7110582 Devenica , D . , Cikes Culic , V . , Vuica , A . , and Markotic , A . ( 2011 ) . Biochemical , pathological and oncological relevance of Gb3Cer receptor . Med . Oncol . 28 ( Suppl . 1 ) : S675 – S684 . doi : 10 . 1007 / s12032 - 010 - 9732 - 8 Dezawa , M . ( 2018 ) . Clinicaltrialsofmusecells . Adv . Exp . Med . Biol . 1103 , 305 – 307 . doi : 10 . 1007 / 978 - 4 - 431 - 56847 - 6 _ 17 Distler , U . , Souady , J . , Hulsewig , M . , Drmic - Hofman , I . , Haier , J . , Friedrich , A . W . , et al . ( 2009 ) . Shiga toxin receptor Gb3Cer / CD77 : tumor - association and promising therapeutic target in pancreas and colon cancer . PLoS ONE 4 : e6813 . doi : 10 . 1371 / journal . pone . 0006813 Eggesbo , J . B . , Hjermann , I . , Hostmark , A . T . , and Kierulf , P . ( 1996 ) . LPS induced release of IL - 1 beta , IL - 6 , IL - 8 and TNF - alpha in EDTA or heparin anticoagulatedwholebloodfrompersonswithhighorlowlevelsofserumHDL . Cytokine 8 , 152 – 160 . doi : 10 . 1006 / cyto . 1996 . 0022 Endo , Y . , and Tsurugi , K . ( 1987 ) . RNA N - glycosidase activity of ricin A - chain . Mechanism of action of the toxic lectin ricin on eukaryotic ribosomes . J . Biol . Chem . 262 , 8128 – 8130 . Engedal , N . , Skotland , T . , Torgersen , M . L . , andSandvig , K . ( 2011 ) . Shigatoxinand its use in targeted cancer therapy and imaging . Microb . Biotechnol . 4 , 32 – 46 . doi : 10 . 1111 / j . 1751 - 7915 . 2010 . 00180 . x Fakhouri , F . , and Loirat , C . ( 2018 ) . Anticomplement treatment in atypical and typical hemolytic uremic syndrome . Semin . Hematol . 55 , 150 – 158 . doi : 10 . 1053 / j . seminhematol . 2018 . 04 . 009 Falguieres , T . , Maak , M . , von Weyhern , C . , Sarr , M . , Sastre , X . , Poupon , M . F . , et al . ( 2008 ) . Human colorectal tumors and metastases express Gb3 and can be targeted by an intestinal pathogen - based delivery tool . Mol . Cancer Ther . 7 , 2498 – 2508 . doi : 10 . 1158 / 1535 - 7163 . MCT - 08 - 0430 Falguieres , T . , Mallard , F . , Baron , C . , Hanau , D . , Lingwood , C . , Goud , B . , et al . ( 2001 ) . Targeting of Shiga toxin b - subunit to retrograde transport route in association with detergent - resistant membranes . Mol . Biol . Cell . 12 , 2453 – 2468 . doi : 10 . 1091 / mbc . 12 . 8 . 2453 Farkas - Himsley , H . , Rosen , B . , Hill , R . , Arab , S . , and Lingwood , C . A . ( 1995 ) . Bacterial colicin active against tumour cells in vitro and in vivo is verotoxin 1 . Proc . Natl . Acad . Sci . U . S . A . 92 , 6996 – 7000 . doi : 10 . 1073 / pnas . 92 . 15 . 6996 Fernandez , G . C . , Lopez , M . F . , Gomez , S . A . , Ramos , M . V . , Bentancor , L . V . , Fernandez - Brando , R . J . , et al . ( 2006 ) . Relevance of neutrophils in the murine model of haemolytic uraemic syndrome : mechanisms involved in Shiga toxin type 2 - induced neutrophilia . Clin . Exp . Immunol . 146 , 76 – 84 . doi : 10 . 1111 / j . 1365 - 2249 . 2006 . 03155 . x Fernandez , G . C . , Rubel , C . , Dran , G . , Gomez , S . , Isturiz , M . A . , and Palermo , M . S . ( 2000 ) . Shiga toxin - 2 induces neutrophilia and neutrophil activation in a murine model of hemolytic uremic syndrome . Clin . Immunol . 95 , 227 – 234 . doi : 10 . 1006 / clim . 2000 . 4862 Flagler , M . J . , Strasser , J . E . , Chalk , C . L . , and Weiss , A . A . ( 2007 ) . Comparative analysis of the abilities of Shiga toxins 1 and 2 to bind to and inﬂuence neutrophil apoptosis . Infect . Immun . 75 , 760 – 765 . doi : 10 . 1128 / IAI . 01594 - 06 Foster , G . H . , Armstrong , C . S . , Sakiri , R . , and Tesh , V . L . ( 2000 ) . Shiga toxin - induced tumor necrosis factor alpha expression : requirement for toxin enzymaticactivityandmonocyteproteinkinaseCandproteintyrosinekinases . Infect . Immun . 68 , 5183 – 5189 . doi : 10 . 1128 / IAI . 68 . 9 . 5183 - 5189 . 2000 Fujii , J . , Matsui , T . , Heatherly , D . P . , Schlegel , K . H . , Lobo , P . I . , Yutsudo , T . , et al . ( 2003 ) . Rapid apoptosis induced by Shiga toxin in HeLa cells . Infect . Immun . 71 , 2724 – 2735 . doi : 10 . 1128 / IAI . 71 . 5 . 2724 - 2735 . 2003 Fujii , J . , Mizoue , T . , Kita , T . , Kishimoto , H . , Joh , K . , Nakada , Y . , et al . ( 2016 ) . Risk of haemolytic uraemic syndrome caused by shiga - toxin - producing Escherichia coli infection in adult women in Japan . Epidemiol . Infect . 144 , 952 – 961 . doi : 10 . 1017 / S0950268815002289 Fuller , C . A . , Pellino , C . A . , Flagler , M . J . , Strasser , J . E . , and Weiss , A . A . ( 2011 ) . Shigatoxinsubtypesdisplaydramaticdiﬀerencesinpotency . Infect . Immun . 79 , 1329 – 1337 . doi : 10 . 1128 / IAI . 01182 - 10 Frontiers in Cellular and Infection Microbiology | www . frontiersin . org 6 March 2020 | Volume 10 | Article 123 Lingwood Receptor Based Pathology Gariepy , J . ( 2001 ) . The use of Shiga - like toxin 1 in cancer therapy . Crit . Rev . Oncol . Hematol . 39 , 99 – 106 . doi : 10 . 1016 / S1040 - 8428 ( 01 ) 00126 - 3 Geelen , J . M . , vanderVelden , T . J . , TeLoo , D . M . , Boerman , O . C . , vandenHeuvel , L . P . , and Monnens , L . A . ( 2007 ) . Lack of speciﬁc binding of Shiga - like toxin ( verocytotoxin ) andnon - speciﬁcinteractionofShiga - liketoxin2antibodywith human polymorphonuclear leucocytes . Nephrol . Dial . Transplant . 22 , 749 – 755 . doi : 10 . 1093 / ndt / gﬂ688 Griener , T . P . , Mulvey , G . L . , Marcato , P . , andArmstrong , G . D . ( 2007 ) . Diﬀerential binding of Shiga toxin 2 to human and murine neutrophils . J . Med . Microbiol . 56 , 1423 – 1430 . doi : 10 . 1099 / jmm . 0 . 47282 - 0 Harada , Y . , Sato , C . , andKitajima , K . ( 2015 ) . Sulfatide - Hsp70interactionpromotes Hsp70 clustering and stabilizes binding to unfolded protein . Biomolecules 5 , 958 – 973 . doi : 10 . 3390 / biom5020958 Hazes , B . , and Read , R . J . ( 1997 ) . Accumulating evidence suggests that several AB - toxins subvert the endoplasmic reticulum - associated protein degradation pathway to enter target cells . Biochemistry 36 , 11051 – 11054 . doi : 10 . 1021 / bi971383p He , X . , Quinones , B . , Loo , M . T . , Loos , S . , Scavia , G . , Brigotti , M . , et al . ( 2015 ) . Serum Shiga toxin 2 values in patients during acute phase of diarrhoea - associated haemolytic uraemic syndrome . Acta Paediatr . 104 , e564 – e568 . doi : 10 . 1111 / apa . 13211 Head , S . , Karmali , M . , and Lingwood , C . A . ( 1991 ) . Preparation of VT1 and VT2 hybrid toxins from their puriﬁed dissociated subunits : Evidence for B subunit modulation of A subunit function . J . Biol . Chem . 266 , 3617 – 3621 . Hebert , D . N . , Bernasconi , R . , and Molinari , M . ( 2010 ) . ERAD substrates : which way out ? Semin . Cell Dev . Biol . 21 , 526 – 532 . doi : 10 . 1016 / j . semcdb . 2009 . 12 . 007 Hooper , N . ( 1999 ) . Detergent - insoluble glycosphingolipid / cholesterol - rich membrane domains , lipid rafts and caveolae . Mol . Membr . Biol . 16 , 145 – 156 . doi : 10 . 1080 / 096876899294607 Hostetter , S . J . , Helgerson , A . F . , Paton , J . C . , Paton , A . W . , and Cornick , N . A . ( 2014 ) . Therapeutic use of a receptor mimic probiotic reduces intestinal Shiga toxin levels in a piglet model of hemolytic uremic syndrome . BMC Res . Notes . 7 : 331 . doi : 10 . 1186 / 1756 - 0500 - 7 - 331 Hurley , B . P . , Thorpe , C . M . , and Acheson , D . W . ( 2001 ) . Shiga Toxin Translocation across intestinal epithelial cells is enhanced by neutrophil transmigration . Infect . Immun . 69 , 6148 – 6155 . doi : 10 . 1128 / IAI . 69 . 10 . 6148 - 6155 . 2001 Jacobson , J . M . , Yin , J . , Kitov , P . I . , Mulvey , G . , Griener , T . P . , James , M . N . , et al . ( 2014 ) . The crystal structure of shiga toxin type 2 with bound disaccharide guides the design of a heterobifunctional toxin inhibitor . J . Biol . Chem . 289 , 885 – 894 . doi : 10 . 1074 / jbc . M113 . 518886 Jandhyala , D . M . , Ahluwalia , A . , Obrig , T . , and Thorpe , C . M . ( 2008 ) . ZAK : a MAP3Kinase that transduces Shiga toxin and ricin induced proinﬂammatory cytokine expression . Cell . Microbiol . 10 , 1468 – 1477 . doi : 10 . 1111 / j . 1462 - 5822 . 2008 . 01139 . x Kamani , M . , Mylvaganam , M . , Tian , R . , Binnington , B . , and Lingwood , C . ( 2011 ) . Adamantyl glycosphingolipids provide a new approach to the selective regulation of cellular glycosphingolipid metabolism . J . Biol . Chem . 286 , 21413 – 21426 . doi : 10 . 1074 / jbc . M110 . 207670 Karmali , M . A . , Petric , M . , Lim , C . , Fleming , P . C . , Arbus , G . S . , and Lior , H . ( 1985 ) . The association between idiopathic hemolytic uremic syndrome and infection by verotoxin - producing Escherichia coli . J . Infect . Dis . 151 , 775 – 782 . doi : 10 . 1093 / infdis / 151 . 5 . 775 Karpman , D . , and Tati , R . ( 2016 ) . Complement contributes to the pathogenesis of Shiga toxin - associated hemolytic uremic syndrome . Kidney Int . 90 , 726 – 729 . doi : 10 . 1016 / j . kint . 2016 . 07 . 002 Katagiri , Y . , Mori , T . , Nakajima , H . , Katagiri , C . , Taguchi , T . , Takeda , T . , et al . ( 1999 ) . Activation of Src family kinase induced by Shiga toxin binding to globotriaosyl ceramide ( Gb3 / CD77 ) in low density , detergent - insoluble microdomains . J . Biol . Chem . 274 , 35278 – 35282 . doi : 10 . 1074 / jbc . 274 . 49 . 35278 Kawano , K . , Okada , M . , Haga , T . , Maeda , K . , and Goto , Y . ( 2008 ) . Relationship between pathogenicity for humans and stx genotype in Shiga toxin - producing Escherichia coli serotype O157 . Eur . J . Clin . Microbiol . Infect . Dis . 27 , 227 – 232 . doi : 10 . 1007 / s10096 - 007 - 0420 - 3 Khan , F . , Proulx , F . , and Lingwood , C . A . ( 2009 ) . Detergent - resistant globotriaosyl ceramide may deﬁne verotoxin / glomeruli - restricted hemolytic uremic syndrome pathology . Kidney Int . 75 , 1209 – 1216 . doi : 10 . 1038 / ki . 2009 . 7 Khine , A . A . , and Lingwood , C . A . ( 1994 ) . Capping and receptor mediated endocytosis of cell bound verotoxin ( Shiga - like toxin ) 1 ; chemical identiﬁcation of an amino acid in the B subunit necessary for eﬃcient receptor glycolipid binding and cellular internalization . J . Cell Physiol . 161 , 319 – 332 . doi : 10 . 1002 / jcp . 1041610217 Khine , A . A . , Tam , P . , Nutikka , A . , and Lingwood , C . A . ( 2004 ) . Brefeldin A and ﬁlipin distinguish two Globotriaosyl ceramide / Verotoxin - 1 intracellular traﬃcking pathways involved in Vero cell cytotoxicity . Glycobiology 14 , 701 – 712 . doi : 10 . 1093 / glycob / cwh085 Kiarash , A . , Boyd , B . , and Lingwood , C . A . ( 1994 ) . Glycosphingolipid receptor function is modiﬁed by fatty acid content : verotoxin 1 and verotoxin 2c preferentiallyrecognizediﬀerentglobotriaosylceramidefattyacidhomologues . J . Biol . Chem . 269 , 11138 – 11146 . Kitov , P . I . , Lipinski , T . , Paszkiewicz , E . , Solomon , D . , Sadowska , J . M . , Grant , G . A . , et al . ( 2008b ) An entropically eﬃcient supramolecular inhibition strategy for Shiga toxins . Angew . Chem . Int . Ed . Engl . 47 , 672 – 676 . doi : 10 . 1002 / anie . 200704064 Kitov , P . I . , Mulvey , G . L . , Griener , T . P . , Lipinski , T . , Solomon , D . , Paszkiewicz , E . , et al . ( 2008a ) . In vivo supramolecular templating enhances the activity of multivalent ligands : a potential therapeutic against the Escherichia coli O157 AB5 toxins . Proc . Natl . Acad . Sci . U . S . A . 105 , 16837 – 16842 . doi : 10 . 1073 / pnas . 0804919105 Kitov , P . I . , Sadowska , J . M . , Mulvey , G . , Armstrong , G . D . , Lingaw , H . , Pannu , N . S . , et al . ( 2000 ) . Shiga - like toxins are neutralized by tailored multivalent carbohydrate ligands . Nature 403 , 669 – 672 . doi : 10 . 1038 / 35001095 Konowalchuk , J . , Speirs , J . I . , and Stavric , S . ( 1977 ) . Vero response to a cytotoxin of Escherichia coli . Infect . Immun . 18 , 775 – 779 . doi : 10 . 1128 / IAI . 18 . 3 . 775 - 779 . 1977 Kovbasnjuk , O . , Mourtazina , R . , Baibakov , B . , Wang , T . , Elowsky , C . , Choti , M . A . , et al . ( 2005 ) . The glycosphingolipid globotriaosylceramide in the metastatic transformation of colon cancer . Proc . Natl . Acad . Sci . U . S . A . 102 , 19087 – 19092 . doi : 10 . 1073 / pnas . 0506474102 Kramer , J . , Deppe , M . , Gobel , K . , Tabelow , K . , Wiendl , H . , and Meuth , S . G . ( 2015 ) . Recovery of thalamic microstructural damage after Shiga toxin 2 - associated hemolytic - uremic syndrome . J . Neurol . Sci . 356 , 75 – 83 . doi : 10 . 1016 / j . jns . 2015 . 06 . 045 Kuroda , S . , Koh , M . , Hori , E . , Hayakawa , Y . , and Akai , T . ( 2018 ) . Muse cell : a new paradigmforcelltherapyandregenerativehomeostasisinischemicstroke . Adv . Exp . Med . Biol . 1103 , 187 – 198 . doi : 10 . 1007 / 978 - 4 - 431 - 56847 - 6 _ 10 Kuroda , Y . , Kitada , M . , Wakao , S . , Nishikawa , K . , Tanimura , Y . , Makinoshima , H . , et al . ( 2010 ) . Unique multipotent cells in adult human mesenchymal cell populations . Proc . Natl . Acad . Sci . U . S . A . 107 , 8639 – 8643 . doi : 10 . 1073 / pnas . 0911647107 LaCasse , E . C . , Bray , M . R . , Patterson , B . , Lim , W . M . , Perampalam , S . , Radvanyi , L . G . , etal . ( 1999 ) . Shiga - liketoxinIreceptoronhumanbreastcancer , lymphoma , and myeloma and absence from CD34 + hematopoietic stem cells : implications for ex vivo tumor purging and autologous stem cell transplantation . Blood 94 , 2901 – 2910 . Lafalla Manzano , A . F . , Gil Lorenzo , A . F . , Bocanegra , V . , Costantino , V . V . , Cacciamani , V . , Benardon , M . E . , et al . ( 2019 ) . Rab7b participation on the TLR4 ( Toll - like receptor ) endocytic pathway in Shiga toxin - associated Hemolytic Uremic Syndrome ( HUS ) . Cytokine 121 : 154732 . doi : 10 . 1016 / j . cyto . 2019 . 05 . 019 Lauvrak , S . U . , Walchli , S . , Iversen , T . G . , Slagsvold , H . H . , Torgersen , M . L . , Spilsberg , B . , et al . ( 2005 ) . Shiga toxin regulates its entry in a syk - dependent manner . Mol . Biol . Cell . 17 , 1096 – 1109 . doi : 10 . 1091 / mbc . e05 - 08 - 0766 Lea , N . , Lord , J . M . , andRoberts , L . M . ( 1999 ) . ProteolyticcleavageoftheAsubunit is essential for maximal cytotoxicity of Escherichia coli O157 : H7 Shiga - like toxin - 1 . Microbiology 145 , 999 – 1004 . doi : 10 . 1099 / 13500872 - 145 - 5 - 999 Leﬄer , J . , Prohaszka , Z . , Mikes , B . , Sinkovits , G . , Ciacma , K . , Farkas , P . , et al . ( 2017 ) . Decreased neutrophil extracellular trap degradation in shiga toxin - associated haemolytic uraemic syndrome . J . Innate . Immun . 9 , 12 – 21 . doi : 10 . 1159 / 000450609 Legros , N . , Pohlentz , G . , Runde , J . , Dusny , S . , Humpf , H . U . , Karch , H . , etal . ( 2017 ) . Colocalization of receptors for Shiga toxins with lipid rafts in primary human renal glomerular endothelial cells and inﬂuence of D - PDMP on synthesis and distribution of glycosphingolipid receptors . Glycobiology 27 , 947 – 965 . doi : 10 . 1093 / glycob / cwx048 Frontiers in Cellular and Infection Microbiology | www . frontiersin . org 7 March 2020 | Volume 10 | Article 123 Lingwood Receptor Based Pathology Leng , Z . , Sun , D . , Huang , Z . , Tadmori , I . , Chiang , N . , Kethidi , N . , et al . ( 2019 ) . Quantitative analysis of SSEA3 + cells from human umbilical cord after magnetic sorting . Cell Transplant . 28 , 907 – 923 . doi : 10 . 1177 / 0963689719844260 Leyva - Illades , D . , Cherla , R . P . , Lee , M . S . , and Tesh , V . L . ( 2012 ) . Regulation of cytokine and chemokine expression by the ribotoxic stress response elicited by Shiga toxin type 1 in human macrophage - like THP - 1 cells . Infect . Immun . 80 , 2109 – 2120 . doi : 10 . 1128 / IAI . 06025 - 11 Ling , H . , Boodhoo , A . , Hazes , B . , Cummings , M . , Armstrong , G . , Brunton , J . , et al . ( 1998 ) . Structureofthe Shigatoxin B - pentamercomplexedwithananalogueof its receptor Gb 3 . Biochem 37 , 1777 – 1788 . doi : 10 . 1021 / bi971806n Lingwood , C . , and Mylvaganam , M . ( 2003 ) . “Lipid Modulation of Glycosphingolipid ( GSL ) receptors : novel soluble GSL mimics provide new probes of GSL receptor function , ” in Meth Enzymol , Vol . 363 , eds Y . C . Lee and R . T . Lee ( San Diego , CA : Academic Press ) , 264 – 283 . doi : 10 . 1016 / S0076 - 6879 ( 03 ) 01057 - 7 Lingwood , C . , Sadacharan , S . , Abul - Milh , M . , Mylvaganum , M . , and Peter , M . ( 2006 ) . Soluble adamantyl glycosphingolipid analogs as probes of glycosphingolipid function . Methods Mol . Biol . 347 , 305 – 320 . doi : 10 . 1385 / 1 - 59745 - 167 - 3 : 305 Lingwood , C . A . ( 1994 ) . Verotoxin - binding in human renal sections . Nephron 66 , 21 – 28 . doi : 10 . 1159 / 000187761 Lingwood , C . A . , Law , H . , Richardson , S . , Petric , M . , Brunton , J . L . , DeGrandis , S . , et al . ( 1987 ) . Glycolipid binding of puriﬁed and recombinant Escherichia coli - produced verotoxin in vitro . J . Biol . Chem . 262 , 8834 – 8839 . Lingwood , D . , Binnington , B . , Róg , T . , Vattulainen , I . , Grzybek , M . , Coskun , U . , et al . ( 2011 ) . Cholesterol modulates glycolipid conformation and receptor activity . Nat . Chem . Biol . 7 , 260 – 262 . doi : 10 . 1038 / nchembio . 551 Loos , S . , Oh , J . , and Kemper , M . J . ( 2018 ) . Eculizumab in STEC - HUS : need for a proper randomized controlled trial . Pediatr . Nephrol . 33 , 1277 – 1281 . doi : 10 . 1007 / s00467 - 018 - 3972 - 9 Lord , J . M . , Deeks , E . , Marsden , C . J . , Moore , K . , Pateman , C . , Smith , D . C . , et al . ( 2003 ) . Retrograde transport of toxins across the endoplasmic reticulum membrane . Biochem . Soc . Trans . 31 , 1260 – 1262 . doi : 10 . 1042 / bst0311260 Louise , C . B . , and Obrig , T . G . ( 1991 ) . Shiga toxin - associated hemolytic - uremic syndrome : combinedcytotoxiceﬀectsofShigatoxin , interleukin - 1ß , andtumor necrosis factor alpha on human vascular endothelial cells in vitro . Infect . Immun . 59 , 4173 – 4179 . doi : 10 . 1128 / IAI . 59 . 11 . 4173 - 4179 . 1991 Mahfoud , R . , Manis , A . , Binnington , B . , Ackerley , C . , and Lingwood , C . A . ( 2010 ) . Amajorfractionofglycosphingolipidsinmodelandcellularcholesterol containing membranes are undetectable by their binding proteins . J . Biol . Chem . 285 , 36049 – 36059 . doi : 10 . 1074 / jbc . M110 . 110189 Mamelak , D . , and Lingwood , C . ( 2001 ) . The ATPase domain of Hsp70 possesses a unique binding speciﬁcity for 3’Sulfogalactolipids . J . Biol . Chem . 276 , 449 – 456 . doi : 10 . 1074 / jbc . M006732200 Mandrell , R . E . , and Apicella , M . A . ( 1993 ) . Lipo - oligosaccharides ( LOS ) of mucosal pathogens : molecular mimicry and host - modiﬁcation of LOS . Immunobiology 187 , 382 – 402 . doi : 10 . 1016 / S0171 - 2985 ( 11 ) 80352 - 9 Matsuoka , K . , Nishikawa , K . , Goshu , Y . , Koyama , T . , Hatano , K . , Matsushita , T . , et al . ( 2018 ) . Synthetic construction of sugar - amino acid hybrid polymers involving globotriaose or lactose and evaluation of their biological activities against Shiga toxins produced by Escherichia coli O157 : H7 . Bioorg . Med . Chem . 26 , 5792 – 5803 . doi : 10 . 1016 / j . bmc . 2018 . 10 . 023 Miura , Y . , Sakaki , A . , Kamihira , M . , Iijima , S . , and Kobayashi , K . ( 2006 ) . A globotriaosylceramide ( Gb3Cer ) mimic peptide isolated from phage display library expressed strong neutralization to Shiga toxins . Biochim . Biophys . Acta 1760 , 883 – 889 . doi : 10 . 1016 / j . bbagen . 2006 . 03 . 018 Miura , Y . , Sasao , Y . , Kamihira , M . , Sakaki , A . , Iijima , S . , and Kobayashi , K . ( 2004 ) . Peptides binding to a Gb3 mimic selected from a phage library . Biochim . Biophys . Acta 1673 , 131 – 138 . doi : 10 . 1016 / j . bbagen . 2004 . 04 . 009 Miyamoto , Y . , Iimura , M . , Kaper , J . B . , Torres , A . G . , and Kagnoﬀ , M . F . ( 2006 ) . Role of Shiga toxin versus H7 ﬂagellin in enterohaemorrhagic Escherichia coli signalling of human colon epithelium in vivo . Cell . Microbiol . 8 , 869 – 879 . doi : 10 . 1111 / j . 1462 - 5822 . 2005 . 00673 . x Mizuguchi , M . , Sugatani , J . , Maeda , T . , Momoi , T . , Arima , K . , Takashima , S . , et al . ( 2001 ) . Cerebrovascular damage in young rabbits after intravenous administration of Shiga toxin 2 . Acta Neuropathol . 102 , 306 – 312 . doi : 10 . 1007 / s004010100384 Monet - Didailler , C . , Chevallier , A . , Godron - Dubrasquet , A . , Allard , L . , Delmas , Y . , Contin - Bordes , C . , et al . ( 2019 ) . Outcome of children with Shiga toxin - associated haemolytic uraemic syndrome treated with eculizumab : a matched cohort study . Nephrol . Dial Transplant . doi : 10 . 1093 / ndt / gfz158 . [ Epub ahead of print ] . Mori , T . , Kiyokawa , N . , Katagiri , Y . U . , Taguchi , T . , Suzuki , T . , Sekino , T . , et al . ( 2000 ) . Globotriaosyl ceramide ( CD77 / Gb3 ) in the glycolipid - enriched membrane domain participates in B - cell receptor - mediated apoptosis by regulating lyn kinase activity in human B cells . Exp . Hematol . 28 , 1260 – 1268 . doi : 10 . 1016 / S0301 - 472X ( 00 ) 00538 - 5 Morigi , M . , Galbusera , M . , Gastoldi , S . , Locatelli , M . , Buelli , S . , Pezzotta , A . , et al . ( 2011 ) . Alternative pathway activation of complement by Shiga toxin promotes exuberant C3a formation that triggers microvascular thrombosis . J . Immunol . 187 , 172 – 180 . doi : 10 . 4049 / jimmunol . 1100491 Mulvey , G . L . , Marcato , P . , Kitov , P . I . , Sadowska , J . , Bundle , D . R . , andArmstrong , G . D . ( 2003 ) . Assessment in mice of the therapeutic potential of tailored , multivalent Shiga toxin carbohydrate ligands . J . Infect . Dis . 187 , 640 – 649 . doi : 10 . 1086 / 373996 Mylvaganam , M . , Binnington , B . , Budani , M . , Soltyk , A . M . , and Lingwood , C . A . ( 2015 ) . The dramatic modulatory role of the 2’N substitution of the terminal amino hexose of globotetraosylceramide in determining binding by members of the verotoxin family . Chromatography 2 , 529 – 544 . doi : 10 . 3390 / chromatography2030529 Mylvaganam , M . , and Lingwood , C . ( 1999 ) . Adamantyl globotriaosyl ceramide - a monovalent soluble glycolipid mimic which inhibits verotoxin binding to its glycolipid receptor . Biochem . Biophys . Res . Commun . 257 , 391 – 394 . doi : 10 . 1006 / bbrc . 1999 . 0474 Nakajima , H . , Kiyokawa , N . , Katagiri , Y . U . , Taguchi , T . , Suzuki , T . , Sekino , T . , etal . ( 2001 ) . Kinetic analysis of binding between Shiga toxin and receptor glycolipid Gb3Cer by surface plasmon resonance . J . Biol . Chem . 276 , 42915 – 42922 . doi : 10 . 1074 / jbc . M106015200 Nakao , H . , and Takeda , T . ( 2000 ) . Escherichia coli Shiga toxin . J . Nat . Toxins . 9 , 299 – 313 . Neri , P . , Nagano , S . I . , Yokoyama , S . , Dohi , H . , Kobayashi , K . , Miura , T . , et al . ( 2007a ) . Neutralizing activity of polyvalent Gb3 , Gb2 and galacto - trehalose models against Shiga toxins . Microbiol . Immunol . 51 , 581 – 592 . doi : 10 . 1111 / j . 1348 - 0421 . 2007 . tb03944 . x Neri , P . , Tokoro , S . , Yokoyama , S . , Miura , T . , Murata , T . , Nishida , Y . , etal . ( 2007b ) . Monovalent Gb3 - / Gb2 - derivatives conjugated with a phosphatidyl residue : a novel class of Shiga toxin - neutralizing agent . Biol . Pharm . Bull . 30 , 1697 – 1701 . doi : 10 . 1248 / bpb . 30 . 1697 Nielsen , H . E . , Truedsson , L . , and Donner , M . ( 1994 ) . Partial complement deﬁciencies in idiopathic thrombocytopenia of childhood . Acta Paediatr . 83 , 749 – 753 . doi : 10 . 1111 / j . 1651 - 2227 . 1994 . tb13132 . x Nishikawa , K . , Matsuoka , K . , Watanabe , M . , Igai , K . , Hino , K . , Hatano , K . , et al . ( 2005 ) . Identiﬁcation of the optimal structure required for a shiga toxin neutralizer with oriented carbohydrates to function in the circulation . J . Infect . Dis . 191 , 2097 – 2105 . doi : 10 . 1086 / 430388 Nishikawa , K . , Watanabe , M . , Kita , E . , Igai , K . , Omata , K . , Yaﬀe , M . B . , etal . ( 2006 ) . A multivalent peptide library approach identiﬁes a novel Shiga toxin inhibitor that induces aberrant cellular transport of the toxin . FASEB . J . 20 , 2597 – 2599 . doi : 10 . 1096 / fj . 06 - 6572fje Nitobe , Y . , Nagaoki , T . , Kumagai , G . , Sasaki , A . , Liu , X . , Fujita , T . , et al . ( 2019 ) . Neurotrophic factor secretion and neural diﬀerentiation potential of multilineage - diﬀerentiating stress - enduring ( muse ) cells derived from mouse adipose tissue . CellTransplant . 28 , 1132 – 1139 . doi : 10 . 1177 / 0963689719863809 Nyholm , P . - G . , and Pascher , I . ( 1993 ) . Orientation of the saccharide chains of glycolipids at the membrane surface : conformational analysis of the glucose - ceramide and the glucose - glyceride linkages using molecular mechanics ( MM3 ) . Biochemistry 32 , 1225 – 1234 . doi : 10 . 1021 / bi00056a005 Nyholm , P . - G . , Samuelsson , B . E . , Breimer , M . , and Pascher , I . ( 1989 ) . Conformational analysis of blood group A - active glycosphingolipids using HSEA - calculations . The possible signiﬁcance of the core oligosaccharide chain for the presentation and recognition of the A - determinant . J . Mol . Recognit . 2 , 103 – 113 . doi : 10 . 1002 / jmr . 300020302 Nyholm , P . G . , Magnusson , G . , Zheng , Z . , Norel , R . , Binnington - Boyd , B . , and Lingwood , C . A . ( 1996 ) . Two distinct binding sites for globotriaosyl ceramide on verotoxins : molecular modelling and conﬁrmation by analogue studies Frontiers in Cellular and Infection Microbiology | www . frontiersin . org 8 March 2020 | Volume 10 | Article 123 Lingwood Receptor Based Pathology and a new glycolipid receptor for all verotoxins . Chem . Biol . 3 , 263 – 275 . doi : 10 . 1016 / S1074 - 5521 ( 96 ) 90106 - 4 Ozuru , R . , Wakao , S . , Tsuji , T . , Ohara , N . , Matsuba , T . , Amuran , M . Y . , et al . ( 2019 ) . Rescue from Stx2 - Producing E . coli - Associated encephalopathy by intravenousinjectionofmusecellsinNOD - SCIDmice . Mol . Ther . 28 , 100 – 118 . doi : 10 . 1016 / j . ymthe . 2019 . 09 . 023 Park , H . J . , McPherson , A . , Fewell , S . , Brodsky , J . , and Lingwood , C . A . ( 2009 ) . A soluble sulfogalactosyl ceramide mimic promotes 1 F508 CFTR escape from endoplasmic reticulum associated degradation ( ERAD ) . Chem . Biol . 16 , 461 – 470 . doi : 10 . 1016 / j . chembiol . 2009 . 02 . 014 Paton , A . W . , Chen , A . Y . , Wang , H . , McAllister , L . J . , Hoggerl , F . , Mayr , U . B . , et al . ( 2015 ) . Protection against shiga - toxigenic escherichia coli by non - genetically modiﬁed organism receptor mimic bacterial ghosts . Infect . Immun . 83 , 3526 – 3533 . doi : 10 . 1128 / IAI . 00669 - 15 Paton , A . W . , Morona , R . , and Paton , J . C . ( 2000 ) . A new biological agent for treatment of Shiga toxigenic Escherichia coli infections and dysentery in humans . Nat . Med . 6 , 265 – 270 . doi : 10 . 1038 / 73111 Paton , A . W . , Morona , R . , and Paton , J . C . ( 2001 ) . Neutralization of Shiga toxins stx1 , stx2c , and stx2e by recombinant bacteria expressing mimics of globotriose and globotetraose . Infect . Immun . 69 , 1967 – 1970 . doi : 10 . 1128 / IAI . 69 . 3 . 1967 - 1970 . 2001 Paton , J . C . , Rogers , T . J . , Morona , R . , and Paton , A . W . ( 2001 ) . Oral administration of formaldehyde - killed recombinant bacteria expressing a mimic of the Shiga toxin receptor protects mice from fatal challenge with Shiga - toxigenic Escherichia coli . Infect . Immun . 69 , 1389 – 1393 . doi : 10 . 1128 / IAI . 69 . 3 . 1389 - 1393 . 2001 Pecoraro , C . , Ferretti , A . V . , Rurali , E . , Galbusera , M . , Noris , M . , and Remuzzi , G . ( 2015 ) . Treatment of congenital thrombotic thrombocytopenic purpura with eculizumab . Am . J . Kidney Dis . 66 , 1067 – 1070 . doi : 10 . 1053 / j . ajkd . 2015 . 06 . 032 Pellizzari , A . , Pang , H . , and Lingwood , C . A . ( 1992 ) . Binding of verocytotoxin 1 to its receptor is inﬂuenced by diﬀerences in receptor fatty acid content . Biochemistry 31 , 1363 – 1370 . doi : 10 . 1021 / bi00120a011 Percheron , L . , Gramada , R . , Tellier , S . , Salomon , R . , Harambat , J . , Llanas , B . , et al . ( 2018 ) . Eculizumab treatment in severe pediatric STEC - HUS : a multicenter retrospective study . Pediatr . Nephrol . 33 , 1385 – 1394 . doi : 10 . 1007 / s00467 - 018 - 3903 - 9 Peter , M . , and Lingwood , C . ( 2000 ) . Apparent cooperativity in multivalent verotoxin globotriaosyl ceramide binding : kinetic and saturation binding experiments with radiolabelled verotoxin [ 125 I ] - VT1 . Biochim . Biophys Acta . 1501 , 116 – 124 . doi : 10 . 1016 / S0925 - 4439 ( 00 ) 00011 - 9 Pezeshkian , W . , Chaban , V . V . , Johannes , L . , Shillcock , J . , Ipsen , J . H . , and Khandelia , H . ( 2015 ) . The eﬀects of globotriaosylceramide tail saturation level on bilayer phases . Soft . Matter . 11 , 1352 – 1361 . doi : 10 . 1039 / C4SM0 2456G Pezeshkian , W . , Gao , H . , Arumugam , S . , Becken , U . , Bassereau , P . , Florent , J . C . , et al . ( 2017 ) . Mechanism of shiga toxin clustering on membranes . ACS Nano 11 , 314 – 324 . doi : 10 . 1021 / acsnano . 6b05706 Ramos , M . V . , Mejias , M . P . , Sabbione , F . , Fernandez - Brando , R . J . , Santiago , A . P . , Amaral , M . M . , etal . ( 2016 ) . Induction ofneutrophilextracellular trapsinshiga toxin - associated hemolytic uremic syndrome . J . Innate . Immun . 8 , 400 – 411 . doi : 10 . 1159 / 000445770 Rasa , M . , Musgrave , J . , Abe , K . , Tanaka , L . , Xoinis , K . , Shiramizu , B . , et al . ( 2017 ) . A case of escherichia coli hemolytic uremic syndrome in a 10 - year - old male with severe neurologic involvement successfully treated with eculizumab . J . Investig . Med . High Impact . Case Rep . 5 : 2324709617741144 . doi : 10 . 1177 / 2324709617741144 Renard , H . F . , Garcia - Castillo , M . D . , Chambon , V . , Lamaze , C . , and Johannes , L . ( 2015 ) . Shigatoxin stimulatesclathrin - independent endocytosis ofVAMP2 / 3 / 8 SNARE proteins . J . Cell Sci . 128 , 2891 – 2902 . doi : 10 . 1242 / jcs . 171116 Roche , J . K . , Keepers , T . R . , Gross , L . K . , Seaner , R . M . , and Obrig , T . G . ( 2007 ) . CXCL1 / KC and CXCL2 / MIP - 2 are critical eﬀectors and potential targets for therapy of Escherichia coli O157 : H7 - associated renal inﬂammation . Am . J . pathol . 170 , 526 – 537 . doi : 10 . 2353 / ajpath . 2007 . 060366 Römer , W . , Berland , L . , Chambon , V . , Gaus , K . , Windschiegl , B . , Tenza , D . , et al . ( 2007 ) . Shiga toxin induces tubular membrane invaginations for its uptake into cells . Nature 450 , 670 – 675 . doi : 10 . 1038 / nature05996 Römer , W . , Pontani , L . L . , Sorre , B . , Rentero , C . , Berland , L . , Chambon , V . , et al . ( 2010 ) . Actin dynamics drive membrane reorganization and scission in clathrin - independent endocytosis . Cell 140 , 540 – 553 . doi : 10 . 1016 / j . cell . 2010 . 01 . 010 Rydell , G . E . , Renard , H . F . , Garcia - Castillo , M . D . , Dingli , F . , Loew , D . , Lamaze , C . , et al . ( 2014 ) . Rab12 localizes to Shiga toxin - induced plasma membrane invaginations and controls toxin transport . Traﬃc 15 , 772 – 787 . doi : 10 . 1111 / tra . 12173 Saito , M . , Mylvaganam , M . , Tam , P . , Binnington , B . , and Lingwood , C . ( 2012 ) . Structure - dependent pseudo - receptor intracellular traﬃc of adamantyl globotriaosyl ceramide mimics . J . Biol . Chem . 287 , 16073 – 16087 . doi : 10 . 1074 / jbc . M111 . 318196 Sandvig , K . , Olnes , S . , Brown , J . , Peterson , O . , and van Deurs , B . ( 1989 ) . Endocytosis from coated pits of Shiga toxin : a glycolipid - binding protein from Shigella dysenteriae 1 . J . Cell Biol . 108 , 1331 – 1343 . doi : 10 . 1083 / jcb . 108 . 4 . 1331 Siegler , R . , Pysher , T . , Tesh , V . , and Taylor , F . ( 2001 ) . Response to single and divided doses of Shiga toxin - 1 in a primate model of hemolytic uremic syndrome . J . Am . Soc . Nephrol . 12 , 1458 – 1467 . Siegler , R . L . , Obrig , T . G . , Pysher , T . J . , Tesh , V . L . , Denkers , N . D . , and Taylor , F . B . ( 2003 ) . Response to Shiga toxin 1 and 2 in a baboon model of hemolytic uremicsyndrome . Pediatr . Nephrol . 18 , 92 – 96 . doi : 10 . 1007 / s00467 - 002 - 1035 - 7 Siegler , R . L . , Pysher , T . J . , Lou , R . , Tesh , V . L . , Taylor , F . B . Jr . ( 2001 ) . Response to Shiga toxin - 1 , with and without lipopolysaccharide , in a primate model of hemolytic uremic syndrome . Am . J . Nephrol . 21 , 420 – 425 . doi : 10 . 1159 / 000046288 Soltyk , A . M . , MacKenzie , C . R . , Wolski , V . M . , Hirama , T . , Kitov , P . I . , Bundle , D . R . , et al . ( 2002 ) . A mutational analysis of the Globotriaosylceramide binding sites of Verotoxin VT1 . J . Biol . Chem . 277 , 5351 – 5359 . doi : 10 . 1074 / jbc . M107472200 Spooner , R . A . , and Lord , J . M . ( 2012 ) . How ricin and Shiga toxin reach the cytosol of target cells : retrotranslocation from the endoplasmic reticulum . Curr . Top . Microbiol . Immunol . 357 , 19 – 40 . doi : 10 . 1007 / 82 _ 2011 _ 154 Stearns - Kurosawa , D . J . , Collins , V . , Freeman , S . , Tesh , V . L . , and Kurosawa , S . ( 2010 ) . Distinct physiologic and inﬂammatory responses elicited in baboons afterchallengewithShigatoxintype1or2fromenterohemorrhagic Escherichia coli . Infect . Immun . 78 , 2497 – 2504 . doi : 10 . 1128 / IAI . 01435 - 09 Stein , P . E . , Boodhoo , A . , Tyrrell , G . J . , Brunton , J . L . , andRead , R . J . ( 1992 ) . Crystal structure of the cell - binding B oligomer of verotoxin - 1 from E . coli . Nature 355 , 748 – 750 . doi : 10 . 1038 / 355748a0 St . Hilaire , P . M . , Boyd , M . K . , and Toone , E . J . ( 1994 ) . Interaction of the Shiga - like toxin type 1 B - subunit with its carbohydrate receptor . Biochemistry 33 , 14452 – 14463 . doi : 10 . 1021 / bi00252a011 Stimmer , L . , Dehay , S . , Nemati , F . , Massonnet , G . , Richon , S . , Decaudin , D . , et al . ( 2014 ) . Human breast cancer and lymph node metastases express Gb3 and can be targeted by STxB - vectorized chemotherapeutic compounds . BMC Cancer 14 : 916 . doi : 10 . 1186 / 1471 - 2407 - 14 - 916 Stults , C . L . M . , Sweeley , C . H . , and Macher , B . A . ( 1989 ) . Glycosphingolipids : structure biological source and properties . Methods Enzymol . 179 , 167 – 214 . doi : 10 . 1016 / 0076 - 6879 ( 89 ) 79122 - 9 Takahashi , K . , Funata , N . , Ikuta , F . , and Sato , S . ( 2008 ) . Neuronal apoptosis and inﬂammatory responses in the central nervous system of a rabbit treated with Shiga toxin - 2 . J . Neuroinﬂammation 5 : 11 . doi : 10 . 1186 / 1742 - 2094 - 5 - 11 Takenaga , M . , Igarashi , R . , Higaki , M . , Nakayama , T . , Yuki , K . , and Mizushima , Y . ( 2000 ) . Eﬀect of a soluble pseudo - receptor on verotoxin2 - induced toxicity . J . Infect . Chemother . 6 , 21 – 25 . doi : 10 . 1007 / s101560050044 Tam , P . , and Lingwood , C . ( 2007 ) . Membrane - cytosolic translocation of Verotoxin A1 - subunit in target cells . Microbiology 153 , 2700 – 2710 . doi : 10 . 1099 / mic . 0 . 2007 / 006858 - 0 Tam , P . , Mahfoud , R . , Nutikka , A . , Khine , A . , Binnington , B . , Paroutis , P . , et al . ( 2008 ) . Diﬀerential intracellular traﬃcking and binding of verotoxin 1 and verotoxin 2 to globotriaosylceramide - containing lipid assemblies . J . Cell Physiol . 216 , 750 – 763 . doi : 10 . 1002 / jcp . 21456 Tareke , E . , Rydberg , P . , Karlsson , P . , Eriksson , S . , and Tornqvist , M . ( 2002 ) . Analysis of acrylamide , a carcinogen formed in heated foodstuﬀs . J . Agric . Food Chem . 50 , 4998 – 5006 . doi : 10 . 1021 / jf020302f Trachtman , H . , Austin , C . , Lewinski , M . , and Stahl , R . A . ( 2012 ) . Renal and neurological involvement in typical Shiga toxin - associated HUS . Nat . Rev . Nephrol . 8 , 658 – 669 . doi : 10 . 1038 / nrneph . 2012 . 196 Trachtman , H . , Cnaan , A . , Christen , E . , Gibbs , K . , Zhao , S . , Acheson , D . W . , et al . ( 2003 ) . Eﬀect of an oral Shiga toxin - binding agent on diarrhea - associated Frontiers in Cellular and Infection Microbiology | www . frontiersin . org 9 March 2020 | Volume 10 | Article 123 Lingwood Receptor Based Pathology hemolytic uremic syndrome in children : a randomized controlled trial . JAMA 290 , 1337 – 1344 . doi : 10 . 1001 / jama . 290 . 10 . 1337 Utskarpen , A . , Massol , R . , van Deurs , B . , Lauvrak , S . U . , Kirchhausen , T . , and Sandvig , K . ( 2010 ) . Shiga toxin increases formation of clathrin - coated pits through Syk kinase . PLoS ONE 5 : e10944 . doi : 10 . 1371 / journal . pone . 0010944 van Setten , P . A . , Monnens , L . A . , Verstraten , R . G . , van den Heuvel , L . P . , and van Hinsbergh , V . W . ( 1996 ) . Eﬀects of verocytotoxin - 1 on nonadherent human monocytes : binding characteristics , protein synthesis , and induction of cytokine release . Blood 88 , 174 – 183 . doi : 10 . 1182 / blood . V88 . 1 . 174 . 174 Voorhees , P . , Deignan , E . , van Donselaar , E . , Humphrey , J . , Marks , M . S . , Peters , P . J . , et al . ( 1995 ) . An acidic sequence within the cytoplasmic domain of furin functions as a determinant of trans - Golgi network localization and internalization from the cell surface . EMBO J . 14 , 4961 – 4975 . doi : 10 . 1002 / j . 1460 - 2075 . 1995 . tb00179 . x Walsh , P . R . , and Johnson , S . ( 2019 ) . Eculizumab in the treatment of Shiga toxin haemolytic uraemic syndrome . Pediatr . Nephrol . 34 , 1485 – 1492 . doi : 10 . 1007 / s00467 - 018 - 4025 - 0 Warnier , M . , Römer , W . , Geelen , J . , Lesieur , J . , Amessou , M . , van den Heuvel , L . , et al . ( 2006 ) . Traﬃcking of Shiga toxin / Shiga - like toxin - 1 in human glomerular microvascular endothelial cells and human mesangial cells . Kidney Int . 70 , 2085 – 2091 . doi : 10 . 1038 / sj . ki . 5001989 Watanabe , M . , Igai , K . , Matsuoka , K . , Miyagawa , A . , Watanabe , T . , Yanoshita , R . , et al . ( 2006 ) . Structural analysis of the interaction between Shiga toxin B subunits and linear polymers bearing clustered globotriose residues . Infect . Immun . 74 , 1984 – 1988 . doi : 10 . 1128 / IAI . 74 . 3 . 1984 - 1988 . 2006 Watanabe , M . , Matsuoka , K . , Kita , E . , Igai , K . , Higashi , N . , Miyagawa , A . , et al . ( 2004 ) . Oral therapeutic agents with highly clustered globotriose for treatment of Shiga toxigenic Escherichia coli infections . J . Infect . Dis . 189 , 360 – 368 . doi : 10 . 1086 / 381124 Watanabe - Takahashi , M . , Sato , T . , Dohi , T . , Noguchi , N . , Kano , F . , Murata , M . , et al . ( 2010 ) . An orally applicable Shiga toxin neutralizer functions in the intestine to inhibit the intracellular transport of the toxin . Infect . Immun . 78 , 177 – 183 . doi : 10 . 1128 / IAI . 01022 - 09 Whetstone , D . , and Lingwood , C . ( 2003 ) . 3’Sulfogalactolipid binding speciﬁcally inhibits Hsp70 ATPase activity in vitro . Biochemistry 42 , 1611 – 1617 . doi : 10 . 1021 / bi026735t Windschiegl , B . , Orth , A . , Römer , W . , Berland , L . , Stechmann , B . , Bassereau , P . , et al . ( 2009 ) . Lipid reorganization induced by Shiga toxin clustering on planar membranes . PLoS ONE 4 : ee6238 . doi : 10 . 1371 / journal . pone . 0006238 Yahi , N . , Aulas , A . , and Fantini , J . ( 2010 ) . How cholesterol constrains glycolipid conformation for optimal recognition of Alzheimer’s beta amyloid peptide ( Abeta1 – 40 ) . PLoS ONE 5 : e9079 . doi : 10 . 1371 / journal . pone . 00 09079 Yamada , S . , Shimizu , M . , Kuroda , M . , Inoue , N . , Sugimoto , N . , and Yachie , A . ( 2019 ) . Interleukin - 33 / ST2 signaling contributes to the severity of hemolytic uremic syndrome induced by enterohemorrhagic Escherichia coli . Clin . Exp . Nephrol . 23 , 544 – 550 . doi : 10 . 1007 / s10157 - 018 - 1675 - y Yamasaki , C . , Nishikawa , K . , Zeng , X . T . , Katayama , Y . , Natori , Y . , Komatsu , N . , et al . ( 2004 ) . Induction of cytokines by toxins that have an identical RNA N - glycosidase activity : shiga toxin , ricin , and modeccin . Biochim . Biophys . Acta 1671 , 44 – 50 . doi : 10 . 1016 / j . bbagen . 2004 . 01 . 002 Young , W . ( 2018 ) . Future of Muse Cells . Adv . Exp . Med . Biol . 1103 , 309 – 315 . doi : 10 . 1007 / 978 - 4 - 431 - 56847 - 6 _ 18 Yu , M . , and Haslam , D . B . ( 2005 ) . Shiga toxin is transported from the endoplasmic reticulum following interaction with the luminal chaperone HEDJ / ERdj3 . Infect . Immun . 73 , 2524 – 2532 . doi : 10 . 1128 / IAI . 73 . 4 . 2524 - 2532 . 2005 Zhang , P . , Paszkiewicz , E . , Wangm , Q . , Sadowska , J . M . , Kitov , P . I . , Bundle , D . R . , et al . ( 2017 ) . Clustering of P ( K ) - trisaccharides on amphiphilic cyclodextrin reveals unprecedented aﬃnity for the Shiga - like toxin Stx2 . Chem . Commun ( Camb ) . 53 , 10528 – 10531 . doi : 10 . 1039 / c7cc06299k Zhang , W . , Bielaszewska , M . , Pulz , M . , Becker , K . , Friedrich , A . W . , Karch , H . , et al . ( 2008 ) . New immuno - PCR assay for detection of low concentrations of shiga toxin 2 and its variants . J . Clin . Microbiol . 46 , 1292 – 1297 . doi : 10 . 1128 / JCM . 02271 - 07 Zhang , X . , McDaniel , A . D . , Wolf , L . E . , Keusch , G . T . , Waldor , M . K . , and Acheson , D . W . ( 2000 ) . Quinolone antibiotics induce Shiga toxin - encoding bacteriophages , toxin production , and death in mice . J . Infect . Dis . 181 , 664 – 670 . doi : 10 . 1086 / 315239 Conﬂict of Interest : CL is a founder of ERAD Therapeutic which is developing bacterial toxoids as treatment for protein misfolding diseases . Copyright © 2020 Lingwood . This is an open - access article distributed under the terms of the Creative Commons Attribution License ( CC BY ) . The use , distribution or reproduction in other forums is permitted , provided the original author ( s ) and the copyright owner ( s ) are credited and that the original publication in this journal is cited , in accordance with accepted academic practice . No use , distribution or reproduction is permitted which does not comply with these terms . Frontiers in Cellular and Infection Microbiology | www . frontiersin . org 10 March 2020 | Volume 10 | Article 123